Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Medical technology & services

Integumen delighted with results of E.Coli detection pilot

The AIM-listed company’s Rinocloud AI platform was used to test samples from a fully autonomous data buoy.

Integumen PLC (LON:SKIN) says a project in Ireland to test reservoir water for E.coli returned results with almost 100% accuracy in a matter of seconds.

The Remote Automated Water Test research project (RAWTest) using Artificial Intelligence (AI) ran for three years at the Inniscarra reservoir in Cork.

Integumen was part of a consortium that also comprised the Irish Environmental Protection Agency (EPA), Cork Institute of Technology (CIT) and the CIT Nimbus embedded systems research institute.

The AIM-listed company’s Rinocloud AI platform was used to test samples from a fully autonomous data buoy.

E.coli bacteria in the water was detected with 99.3% accuracy in 3.37 seconds compared to current standard test detection time of between 5-7 days.

Wireless transmission of water data for 13 key AI features indicators was identified from more than 1000 data elements.

Integumen believes there is potential for Rawtest’s remote monitoring to be applied to public buildings to test for listeria; for malaria in third-world countries; milk contamination and in fermentation processes such as brewing.

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK